Reaction
Pancreatitis Relapsing reporting signals
As of the last recalculation, Pancreatitis Relapsing appears in 801 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is DIMENHYDRINATE (PRR 55.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dimenhydrinate | 22 | 55.1 | 55.2 |
| Ciclesonide | 22 | 43.1 | 43.2 |
| Pancrelipase | 46 | 32.8 | 32.8 |
| Abacavir Sulfate | 12 | 32.5 | 32.5 |
| Carboxymethylcellulose Sodium | 11 | 30.8 | 30.9 |
| Mometasone | 21 | 30.5 | 30.6 |
| Ursosiol | 20 | 27.4 | 27.4 |
| Ampicillin | 8 | 25.3 | 25.4 |
| Ampicillin Sodium | 8 | 25.3 | 25.4 |
| Minocycline | 11 | 24.8 | 24.9 |
| Ursodiol | 20 | 24.4 | 24.5 |
| Tenofovir Disoproxil Fumarate Tablets | 8 | 24.3 | 24.3 |
| Ritonavir 100 Mg | 13 | 23.0 | 23.0 |
| Exenatide | 44 | 22.9 | 23.0 |
| Amitriptyline Hydrochloride | 15 | 22.6 | 22.6 |
| Gemfibrozil | 12 | 20.8 | 20.9 |
| Nevirapine | 7 | 20.3 | 20.3 |
| Ivacaftor | 6 | 19.8 | 19.8 |
| Fenofibrate | 25 | 18.9 | 18.9 |
| Niacin | 8 | 18.1 | 18.1 |
| Ziprasidone Mesylate | 7 | 12.9 | 12.9 |
| Icosapent Ethyl | 4 | 12.3 | 12.3 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 13 | 11.0 | 11.0 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 4 | 8.4 | 8.4 |
| Alirocumab | 6 | 6.3 | 6.3 |
| Orlistat | 5 | 5.0 | 5.0 |